tirzepatide surpass cvot 🫀 EASD 2025: (SURPASS-CVOT) Dulaglutide head-to-head showdown: ✓ Noninferior for MACE ✓ 16% ↓ all-cause mortality ✓ Superior in A1C & weight loss Tirzepatide confirms its broad cardiometabolic edge. #EASD2025 # Tirzepatide #GLP1 tirzepatide and cardiovascular outcomes In

A pill version of the weight-loss and diabetes drug, semaglutide, could benefit people with heart failure Taking the weight loss and diabetes drug semaglutide orally, rather than as an injection, helped patients with diabetes and heart failure to avoid serious outcomes, including hospitalisation, urgent doctor visits and death, according to an analysis of previous trial data

In Canada, Apo-Semaglutide Injection is indicated for the once-weekly treatment of adults with type 2 #diabetes mellitus to improve glycemic control, in combination with #diet and #exercise

Tired of feeling tired? GLP-1 therapies can often leave you feeling drained, but PeptideComfort tackles this head-on

PPH may cause severe symptoms or be asymptomatic

Retatrutide 20mg is part of the Aegis Peptides Retatrutide research product range

This state-of-the-art review comprehensively analyzes current evidence from clinical trials, identifies critical insights, and outlines research directions regarding semaglutide use in HF, ASCVD, and diabetic nephropathy